| 标题 |
The PBPK LeiCNS-PK3.0 framework predicts Nirmatrelvir (but not Remdesivir or Molnupiravir) to achieve effective concentrations against SARS-CoV-2 in human brain cells |
| 网址 | |
| DOI | |
| 其它 |
期刊:European Journal of Pharmaceutical Sciences 作者:Mohammed A.A. Saleh; Makoto Hirasawa; Ming Sun; Berfin Gülave; Jeroen Elassaiss-Schaap; et al 出版日期:2023-02-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)